The production of chemical and pharmaceutical products in France has experienced variability from 2013 to 2023. The most significant downturn occurred in 2020 with a notable -16.38% decrease. Recovery was significant in 2021 with a 33.75% increase. By 2023, production stood at 97.88 billion Euros, maintaining a positive trajectory with an increase of 0.87% from the previous year. Over the last five years, the Compound Annual Growth Rate (CAGR) was 0.95%.
From 2024 onwards, forecasted data suggest a stable upward trend, with production projected to reach 102.83 billion Euros by 2028. The forecasted 5-year CAGR is 0.67%, with a cumulative growth rate of 3.37%.
Future trends to watch include technological advancements in production processes, regulatory changes, and potential impacts from global supply chain disruptions. Focus will also be on how the industry adapts to environmental sustainability demands and innovation in pharmaceutical development.
